Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic Liver Disease in Newly Diagnosed People Living With HIV: MASHIV-TR Cohort (MASHIV-TR)

NCT07737340 is registered in ClinicalTrials.gov with Yaşar Bayındır, MD as lead sponsor.

NCT NCT07737340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07737340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic Liver Disease in Newly Diagnosed People Living With HIV: MASHIV-TR Cohort (MASHIV-TR)
Lead sponsor
Yaşar Bayındır, MD
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2024
Completion date
May 31, 2029
Enrollment
411 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver, hiv infections, metabolic dysfunction-associated steatotic liver disease (masld) & steatohepatitis (mash)